Tomomi Kamba

4.6k total citations · 2 hit papers
152 papers, 3.3k citations indexed

About

Tomomi Kamba is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Tomomi Kamba has authored 152 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 38 papers in Surgery and 37 papers in Molecular Biology. Recurrent topics in Tomomi Kamba's work include Prostate Cancer Treatment and Research (43 papers), Renal cell carcinoma treatment (31 papers) and Prostate Cancer Diagnosis and Treatment (27 papers). Tomomi Kamba is often cited by papers focused on Prostate Cancer Treatment and Research (43 papers), Renal cell carcinoma treatment (31 papers) and Prostate Cancer Diagnosis and Treatment (27 papers). Tomomi Kamba collaborates with scholars based in Japan, United States and Netherlands. Tomomi Kamba's co-authors include Donald M. McDonald, Osamu Ogawa, Takahiro Inoue, Toshinari Yamasaki, Takashi Kobayashi, Naoki Terada, Toshiyuki Kamoto, Calvin J. Kuo, Betty Y. Tam and Karen E. Anderson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Tomomi Kamba

140 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of adverse effects of anti-VEGF therapy for cancer

2007 767 citations Tomomi Kamba et al. profile →
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

2005 630 citations Tomomi Kamba et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomomi Kamba Japan	27	1.3k	1.2k	1.0k	635	371	152	3.3k
Noboru Nakaigawa Japan	30	1.8k 1.4×	1.5k 1.3×	719 0.7×	734 1.2×	475 1.3×	127	3.3k
Tomohiko Asano Japan	27	1.5k 1.1×	804 0.7×	1.0k 1.0×	635 1.0×	763 2.1×	180	3.6k
Nina J. Karlin United States	15	1.4k 1.1×	969 0.8×	2.2k 2.1×	1.1k 1.7×	430 1.2×	47	4.1k
Petr Kavan Canada	29	1.0k 0.8×	1.1k 1.0×	1.5k 1.4×	876 1.4×	390 1.1×	141	4.4k
Jean Charles Soria France	25	1.5k 1.1×	965 0.8×	1.2k 1.2×	561 0.9×	252 0.7×	48	3.1k
Motohide Uemura Japan	31	1.6k 1.2×	1.2k 1.0×	858 0.8×	1.0k 1.6×	624 1.7×	196	3.3k
Yang Lü United States	35	1.9k 1.4×	971 0.8×	1.9k 1.8×	906 1.4×	491 1.3×	171	4.5k
Hiroyuki Takahashi Japan	31	1.2k 0.9×	1.3k 1.1×	879 0.8×	555 0.9×	621 1.7×	148	3.3k
Takeshi Ueda Japan	32	1.8k 1.3×	2.0k 1.6×	1.2k 1.2×	899 1.4×	604 1.6×	156	4.2k

Countries citing papers authored by Tomomi Kamba

Since Specialization

Citations

This map shows the geographic impact of Tomomi Kamba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomomi Kamba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomomi Kamba more than expected).

Fields of papers citing papers by Tomomi Kamba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomomi Kamba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomomi Kamba. The network helps show where Tomomi Kamba may publish in the future.

Co-authorship network of co-authors of Tomomi Kamba

This figure shows the co-authorship network connecting the top 25 collaborators of Tomomi Kamba. A scholar is included among the top collaborators of Tomomi Kamba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomomi Kamba. Tomomi Kamba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sakamoto, Yasuhisa, Shinya Wada, Masahiro Wakao, et al.. (2025). Peptide Modulation Overrides Glycan Synergy in Gold Nanoparticle‐Based Vaccines for Cancer Immunotherapy. Cancer Medicine. 14(19). e71286–e71286.

Inokuchi, Junichi, Tomoaki Hakariya, Hideki Enokida, et al.. (2024). Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu–Okinawa area of Japan. International Journal of Urology. 31(5). 484–491. 1 indexed citations

Kuroda, Seiji, Takanobu Motoshima, Yorifumi Satou, et al.. (2024). ARID2 Deficiency Enhances Tumor Progression via ERBB3 Signaling in TFE3-Rearranged Renal Cell Carcinoma. Current Issues in Molecular Biology. 46(12). 13675–13695.

Shiota, Masaki, Tokiyoshi Tanegashima, Shuichi Tatarano, et al.. (2024). The effect of human leukocyte antigen genotype on survival in advanced prostate cancer treated with primary androgen deprivation therapy: the KYUCOG-1401-A study. Prostate Cancer and Prostatic Diseases. 28(1). 193–201. 1 indexed citations

Shiota, Masaki, Shuichi Tatarano, Toshiyuki Kamoto, et al.. (2024). Predictive model of castration resistance in advanced prostate cancer by machine learning using genetic and clinical data: KYUCOG-1401-A study. SHILAP Revista de lepidopterología. 2(1). 69–69. 1 indexed citations

Yano, Hiromu, Takanobu Motoshima, Junji Yatsuda, et al.. (2024). Potential protumor function of CD74 in clear cell renal cell carcinoma. Human Cell. 37(5). 1535–1543. 2 indexed citations

Miura, Yuji, Takanobu Motoshima, Hiromu Yano, et al.. (2023). Predictive value of CXCL10 for the occurrence of immune‐related adverse events in patient with renal cell carcinoma. Microbiology and Immunology. 67(7). 345–354. 7 indexed citations

Motoshima, Takanobu, Junji Yatsuda, Yoji Murakami, et al.. (2023). Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma. IJU Case Reports. 6(2). 147–149. 2 indexed citations

Pan, Cheng, Yukio Fujiwara, Yoshihiro Komohara, et al.. (2023). Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy. Cancer Science. 115(1). 59–69. 6 indexed citations

10.

Sakamoto, Hiromasa, Toshinari Yamasaki, Takayuki Sumiyoshi, et al.. (2020). Functional and genomic characterization of patient‐derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma. Cancer Medicine. 10(1). 119–134. 5 indexed citations

11.

Funada, Satoshi, Takahisa Kawaguchi, Naoki Terada, et al.. (2016). Population-Based Survey of Overactive Bladder in Japan: A Cross-Sectional Analysis of the Nagahama study. Neurourology and Urodynamics. 1 indexed citations

12.

Ito, Noriyuki, Shinsuke Kojima, Satoshi Teramukai, et al.. (2015). Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment. International Journal of Clinical Oncology. 20(6). 1161–1170. 5 indexed citations

13.

Kawai, Koji, Tomomi Kamba, Keiji Uchida, et al.. (2014). Risk Factors for Loss to Follow-up During Active Surveillance of Patients with Stage I Seminoma. Japanese Journal of Clinical Oncology. 44(4). 355–359. 8 indexed citations

14.

Kamba, Tomomi, Toshinari Yamasaki, Satoshi Teramukai, et al.. (2013). Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice. International Journal of Clinical Oncology. 19(3). 505–515. 10 indexed citations

15.

Sugino, Yoshio, Koji Yoshimura, Yoshiyuki Matsui, et al.. (2012). Assessment of lower urinary tract symptoms after Bacille Calmette-Guérin instillation therapy for non muscle-invasive bladder cancer. 1 indexed citations

16.

Eto, Masatoshi, Tomomi Kamba, Hideaki Miyake, et al.. (2012). STAT3 Polymorphism Can Predict the Response to Interferon-α Therapy in Patients with Metastatic Renal Cell Carcinoma. European Urology. 63(4). 745–752. 26 indexed citations

17.

Shimizu, Yosuke, Yoko Hamazaki, Masakazu Hattori, et al.. (2011). SPA‐1 controls the invasion and metastasis of human prostate cancer. Cancer Science. 102(4). 828–836. 34 indexed citations

18.

Mizuno, Tomoyuki, Tomohiro Terada, Jun Watanabe, et al.. (2010). Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study. International Journal of Clinical Oncology. 15(5). 512–514. 18 indexed citations

19.

Kamba, Tomomi, Akihiro Kanematsu, Jun Watanabe, et al.. (2009). [A case of elderly donor in living kidney transplant after radical radiotherapy for prostate cancer].. PubMed. 55(10). 623–5. 1 indexed citations

20.

OGASAWARA, K., Tomohiro Terada, Hideyuki Motohashi, et al.. (2008). Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney. Journal of Human Genetics. 53(7). 607–614. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact